The tyrosine kinase receptor ROR1 gene, which is involved in the peptidyl-tyrosine modification pathway, was reported to be upregulated in CLL patients (Hojjat-Farsangi et al., 2015). This evidence concerns the gene NTRK1 and B-cell chronic lymphocytic leukemia.